Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - QUIDEL CORP /DE/ | d495302d8k.htm |
| EX-10.2 - EX-10.2 - QUIDEL CORP /DE/ | d495302dex102.htm |
| EX-10.4 - EX-10.4 - QUIDEL CORP /DE/ | d495302dex104.htm |
| EX-10.5 - EX-10.5 - QUIDEL CORP /DE/ | d495302dex105.htm |
| EX-10.1 - EX-10.1 - QUIDEL CORP /DE/ | d495302dex101.htm |
Exhibit 10.3
2013 Equity Incentive Plan
The 2013 Equity Incentive Plan provides for the issuance of equity incentive awards in the form of (i) non-qualified stock options; and (ii) time-based restricted stock units.
| Executive Officer |
Time-Based Restricted Stock Units (# shares) |
Non-Qualified Stock Options (# shares) |
||||||
| Douglas Bryant President and Chief Executive Officer |
4,389 | 92,326 | ||||||
| Robert Bujarski Senior Vice President, Business Development and General Counsel |
1,350 | 28,408 | ||||||
| Mark Smits Senior Vice President, Commercial Operations, North America |
1,575 | 33,142 | ||||||
| Timothy Stenzel Chief Scientific Officer |
1,125 | 23,673 | ||||||
| Randall Steward Chief Financial Officer |
1,801 | 37,877 | ||||||
| John Tamerius Senior Vice President, Clinical and Regulatory Affairs |
900 | 18,938 | ||||||
The vesting period for the non-qualified stock options and restricted stock units is over four years with the first 50% of such equity awards vesting at the end of the second-year anniversary of the grant date and the remainder vesting 25% annually on each of the following two anniversaries thereafter.